Home Search Abstracts Browse Oral Sessions Browse Poster Sessions
Session 58  Poster Abstracts
Factors Impacting Viral Replication in vivo
Monday, 1-4 pm
Room: Hall D
      308 Increased Levels of APOBEC3G mRNA in Highly Exposed Persistently Seronegative Individuals and Individuals with Long Term Low Viral Loads
Joel Vazquez-Perez*, R Hernandez, C Ormsby, and G Reyes-Teran
Natl Inst of Respiratory Diseases, Mexico City, Mexico
      309 Levels of APOBEC3G and APOBEC3F mRNA Increase Post HIV-1 Infection Associated with Low Viral Set-point
Nzovu Ulenga*1, A Dieng Sarr1, S Thakore-Meloni1, J L Sankale1, G Eisen1, A Gueye-NDiaye2, S MBoup2, and P Kanki1
1Harvard Sch of Publ Hlth, Boston, MA, US and 2Cheikh Anta Diop Univ, Dakar, Senegal
      310 Viral Replication is Sustained by Short-lived Infected Cells in SIVagm-infected African Green Monkeys
Ivona Pandrea*1, R Ribeiro2, R Gautam1, T Gaufin1, C Monjure1, M Pattison1, G Silvestri3, M Miller4, A Perelson2, and C Apetrei1
1Tulane Natl Primate Res Ctr, Covington, LA, US; 2Los Alamos Natl Lab, NM, US; 3Univ of Pennsylvania, Philadelphia, US; and 4Gilead Sci, Foster City, CA, US
      311 Evolution in HIV-1 gag and env Is Differentially Associated with Viral Load and the Immune Response at Different Times in Infection
Anne Piantadosi*1,2, B Chohan1,2, D Panteleeff1, Z Jalalian-Lechak1, J Baeten2, and J Overbaugh1
1Fred Hutchinson Cancer Res Ctr, Seattle, WA, US and 2Univ of Washington, Seattle, US
      312 Genome-wide HLA-associated Selection in HIV-1 and Protein-specific Correlations with Viral Load: An ACTG5142 Study
M John1, D Heckerman2, L Park1, S Gaudieri1, A Chopra1, J Carlson2, I James1, D Nolan1, R Haubrich3, Simon Mallal*1, and ACTG 5142 study team
1Ctr for Clinical Immunology and Biomed Statistics, Murdoch Univ, Royal Perth Hosp, Australia; 2Microsoft Res, Redmond WA, US; and 3Antiviral Res Ctr, San Diego, CA, US
      313 Contribution of NK Cells to the Control of Primary SIV Infection in Rhesus Monkeys
Elisa Choi*, N Letvin, K Reimann, and CHAVI - Center for HIV-AIDS Vaccine Immunology
Beth Israel Deaconess Med Ctr, Boston, MA, US
      314 Higher Frequencies of Gamma delta T Cells Are Associated with Undetectable Plasma Viral Loads in HIV-2 Infections
N Zheng1,2, J McElrath1,2, S Sow3, A Mesher1, S Hawes1, J Stern1, Geoffrey Gottlieb*1, S DE Rosa1,2, and N Kiviat1
1Univ of Washington, Seattle, US; 2Fred Hutchinson Cancer Res Ctr, Seattle, WA, US; and 3Univ of Dakar, Senegal
      315 HIV-1-induced Activation of CD4+ T Cells Creates New Targets for HIV-1 Infection in Human Lymphoid Tissue ex vivo
Angelique Biancotto*1, J C Grivel1, I Hirsch2, C Vanpouille1, A Lisco1, and L Margolis1
1Natl Inst of Child Hlth and Human Devt, NIH, Bethesda, MD, US and 2INSERM UMR 599, Marseille, France
      316 Alloantigen Exposure Alters the Susceptibility to Cell-associated Mucosal FIV Challenge
Surender Kumar*, S Leavell, B Assogba, and M Burkhard
Ohio State Univ, Columbus, OH, US
      317 WFDC1/ps20 Is a Novel Innate Immunomodulatory Signature Protein of HIV permissive CD4+CD45RO+ Memory T Cells that Promotes Infection by Up-regulating CD54 Integrin Expression and Is Elevated in HIV-1 Infection
Raymond Alvarez*, J Reading, P Easterbrook, and A Vyakarnam
King`s Coll London, UK
      318 Foreskin Langerhans' Cell Density of HIV Infected and Uninfected Men in Rakai, Uganda
Kristine Johnson*1, J Taube1, R Sharma1, A Rabkin2, D Serwadda3, G Kigozi3, S Watya3, M Wawer3,4, R Gray3,4, and T Quinn1,5
1Johns Hopkins Univ Sch of Med, Baltimore, MD, US; 2Stanford Univ, Palo Alto, CA, US; 3Rakai Hlth Sci Prgm, Kalisizo, Uganda; 4Johns Hopkins Univ Bloomberg Sch of Publ Hlth, Baltimore, MD, US; and 5NIAID, NIH, Bethesda, MD, US